Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017

Details for Mechanism ID: 17286
Country/Region: India
Year: 2017
Main Partner: Science Health Allied Research Education Foundation
Main Partner Program: India
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $100,000 Additional Pipeline Funding: $700,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $100,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 86
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 3,967
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 253
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 4,138
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 9,056
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 8,444
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 90
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 4,056
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 267
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 4,443
TB_PREV By Age/Sex (Numerator): <15, Female 2018 467
TB_PREV By Age/Sex (Numerator): <15, Male 2018 1,387
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 22,091
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 23,026
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 46,993
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 58,737
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 588
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 1,762
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 27,603
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 28,784
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 102,794
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 9,056
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 90
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 269
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 4,259
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 4,438
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 1,024
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 3,081
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 48,316
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 50,373